In tumors such as hepatocellular carcinoma, gastric cancer, and breast cancer, high METTL16 expression is frequently correlated with enhanced tumor invasiveness, poor differentiation, and reduced overall survival (57). The gene discussed is METTL16; the disease is breast cancer.